Clinical Trials Related to Chronic GVHD

Related studies linked through entity extraction aliases.

Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Status: WITHDRAWN
Phase: PHASE2

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Status: TERMINATED
Phase: PHASE2

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Status: COMPLETED
Phase: PHASE2

SHR0302 and Steroid As First Line Therapy for Chronic GVHD

Status: COMPLETED
Phase: EARLY_PHASE1

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

Status: COMPLETED
Phase: PHASE2/PHASE3